DCT

2:22-cv-03044

Aragon Pharma Inc v. Sandoz Inc

General
Filed
05/24/22
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (08/10/23)
Patent Owner
NPE (L)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
65%